Bristol Myers Squibb on Thursday posted better-than-expected fourth quarter earnings, but said its 2025 revenue would fall ...

By Michael Erman and Sriparna Roy (Reuters) -Bristol Myers Squibb on Thursday said its 2025 revenue would fall more sharply ...

Ed: As usual, a disappointing lack of ambition from the senior management to push hard for promotion. They blame the transfer ...

Bristol Myers Squibb reported strong fourth-quarter earnings but its outlook for 2025 failed to meet expectations.

The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face ...

The Bristol Township man has pleaded guilty to felony and misdemeanor charges for using a spy camera to film his girlfriend's ...

BMS is not the only U.S. pharma giant making massive cuts. Last year, Pfizer revealed a similar plan to reduce $1.5 billion ...

The University of Bristol Student’s Union has passed a motion to make the entire university plant-based. The Annual Members ...

Bristol-Myers Squibb Company (NYSE:BMY) slid more than 2% in premarket trading Thursday after the company's guidance for 2025 missed average analyst expectations.

A Bristol fly-tipper fined almost £900 after he blocked country lane with dumped rubbish. James Talbot, 29, of East Parade in ...

Bristol Myers Squibb beat Q4 estimates with $12.34 billion revenue and $1.67 EPS. 2025 guidance lags expectations amid ...

Bristol Myers (BMY) delivered earnings and revenue surprises of 14.38% and 6.59%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?